Stacy Lindborg

Stacy Lindborg has a strong background in the pharmaceutical and biotech industry. Stacy currently serves as the Co-Chief Executive Officer at Brainstorm Cell Therapeutics, where they are responsible for driving clinical development strategies. Prior to that, they held various executive roles at Biogen, including Vice President of Analytics and Data Science. Stacy also has experience in leadership positions at Eli Lilly and Company, where they were involved in global statistics, research and development strategy, and product management. In addition to their industry experience, they are currently a board director at IMUNON and the Chair of the Board of Directors at Massachusetts Down Syndrome Congress.

Stacy Lindborg received their Ph.D. degree in Statistics from Baylor University. Stacy completed their doctoral studies from 1992 to 1996. In August 2008, they obtained the certification of American Statistical Association Fellow from the American Statistical Association (ASA).